Literature DB >> 23183586

Interaction between the regulatory domain of cardiac troponin C and the acidosis-resistant cardiac troponin I A162H.

Sandra E Pineda-Sanabria1, Ian M Robertson, Monica X Li, Brian D Sykes.   

Abstract

AIMS: Ischaemic heart disease is the leading cause of mortality worldwide. Acidosis is the main mediator of ischaemia and shielding against it might be possible. In this study, we characterize the nature of interaction between the regulatory domain of cardiac troponin C and the A162H-substituted cardiac troponin I (cTnI) that confers protection against acidosis. METHODS AND
RESULTS: We used nuclear magnetic resonance spectroscopy to study the interaction of the Ca(2+)-saturated N-domain of cardiac troponin C with the switch region of cTnI containing the A162H substitution under normal and acidic conditions. Our results show that H162 increases the affinity of TnI for troponin C at pH 7 and this affinity is further enhanced at pH 6. To investigate the nature of the interactions responsible for such improvement, we determined the acid dissociation constants of the glutamate residues in troponin C. The results show that E15 and E19 exhibit deviations in their acid dissociation constant (pK(a)) profiles and reflect a common high pK(a) value of 6.8, indicating electrostatic interactions with H162. Residue H171 in wild-type cTnI does not play a similar role.
CONCLUSION: This work provides evidence for the mechanism by which cTnI A162H improves myocardial performance during acidosis. The electrostatic interaction between residues E15 and E19 in troponin C and H162 in TnI at low pH is responsible for stabilizing the conformation of troponin C that leads to contraction, thus partially ablating the decreased Ca(2+)-sensitivity caused by acidosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23183586     DOI: 10.1093/cvr/cvs348

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  5 in total

1.  Molecular determinants of cardiac myocyte performance as conferred by isoform-specific TnI residues.

Authors:  Brian R Thompson; Evelyne M Houang; Yuk Y Sham; Joseph M Metzger
Journal:  Biophys J       Date:  2014-05-20       Impact factor: 4.033

Review 2.  Cell biology of sarcomeric protein engineering: disease modeling and therapeutic potential.

Authors:  Brian R Thompson; Joseph M Metzger
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

3.  X-ray structure of a human cardiac muscle troponin C/troponin I chimera in two crystal forms.

Authors:  Chunhong Yan; John S Sack
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2022-01-01       Impact factor: 1.056

Review 4.  Structure and function of cardiac troponin C (TNNC1): Implications for heart failure, cardiomyopathies, and troponin modulating drugs.

Authors:  Monica X Li; Peter M Hwang
Journal:  Gene       Date:  2015-07-29       Impact factor: 3.688

5.  TnI Structural Interface with the N-Terminal Lobe of TnC as a Determinant of Cardiac Contractility.

Authors:  Anthony D Vetter; Evelyne M Houang; Jordan J Sell; Brian R Thompson; Yuk Y Sham; Joseph M Metzger
Journal:  Biophys J       Date:  2018-04-10       Impact factor: 4.033

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.